Growth Metrics

Aclarion (ACONW) Debt to Equity (2023 - 2026)

Aclarion posted quarterly Debt to Equity of $0.0 for Q1 2026, down 53.35% on a QoQ basis from $0.0 in Q4 2025.

Aclarion (ACONW) has 4 years of Debt to Equity data on file, last reported at $0.0 in Q1 2026.

  • For the quarter ending Q1 2026, Debt to Equity changed N/A year-over-year to $0.0; the trailing twelve-month figure through Mar 2026 stood at $0.0 (changed N/A YoY), and the FY2025 full-year result was $0.0, down 99.96% from the prior year.
  • Debt to Equity for Q1 2026 stood at $0.0, down from $0.0 in the prior quarter.
  • Across five years, Debt to Equity topped out at $16.86 in Q2 2023 and bottomed at -$0.44 in Q3 2023.
  • The 4-year median for Debt to Equity is $0.01 (2024), against an average of $2.04.
  • The widest annual swing landed in 2024, when Debt to Equity soared 107.34%; it then tumbled 99.96% in 2025.
  • A 4-year view of Debt to Equity shows it stood at -$0.17 in 2023, then soared by 107.34% to $0.01 in 2024, then sank by 99.96% to $0.0 in 2025, then plunged by 53.35% to $0.0 in 2026.
  • The last three Debt to Equity figures came in at $0.0 (Q1 2026), $0.0 (Q4 2025), and $0.01 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 1.26
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 0.46
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 0.37
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 Aclarion - - 3,750.00 0.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Dec 31, 2024 0.01
Jun 30, 2024 0.01
Mar 31, 2024 0.01
Dec 31, 2023 -0.17
Sep 30, 2023 -0.44
Jun 30, 2023 16.86